US BANCORP DE USB-PA
NYSE · stock · National Commercial Banks
6/9
Piotroski F — financial health
—
Altman Z″ — distress risk
41.8%
Dividend payout · moderate
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $28.7B | $7.6B | — | — | $65.7B |
| 2024 | $27.5B | $6.3B | — | — | $59.0B |
| 2023 | $28.1B | $5.4B | — | — | $55.8B |
| 2022 | $24.3B | $5.8B | — | — | $51.2B |
| 2021 | — | $8.0B | — | — | $55.4B |
| 2020 | — | $5.0B | — | — | $53.7B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Dilip Venkatachari | SEVP & Chief Info & Tech Off | 2026-05-05 | Sell | 34,522 | $55.52 |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0000036104 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.